Notably, in some therapy-resistant cancer cells with mesenchymal cell-state contexts, inhibition of GPX4 could effectively sensitize cells to ferroptosis (Hangauer et al. 2017; Viswanathan et al. 2017). The gene discussed is GPX4; the disease is cancer.